FDA, Immunization and Research Laboratories

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Immunization

Research Laboratories

US FDA grants approval for Merck’s pneumococcal vaccine for children

Pharmaceutical Technology

JUNE 23, 2022

The US Food and Drug Administration (FDA) has granted approval for Merck's (MSD outside the US and Canada) pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for use in children aged six weeks to 17 years. The post US FDA grants approval for Merck’s pneumococcal vaccine for children appeared first on Pharmaceutical Technology.

Vaccines

Vaccines FDA Research Laboratories Immunization

Keytruda approved as first-line advanced cervical cancer therapy

pharmaphorum

OCTOBER 14, 2021

The FDA has approved Merck’s Keytruda as a first-line therapy for advanced cervical cancer. Some cancer cells contain large amounts of PD-L1, which helps them to evade the body’s immune system. The protein, Programmed Death-Ligand 1 (PD-L1), is found on the surface of many cells throughout the body.

Chemotherapy

Chemotherapy Research Laboratories Immunization FDA

Pharmacy Technician Pulse

US FDA grants approval for Merck’s pneumococcal vaccine for children

Keytruda approved as first-line advanced cervical cancer therapy

Stay Connected